Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Marosi

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Endokrinologie|June 1, 1976
Lengthening of the duration of action of DDAVP by "ineffective" doses of clofibrate in patients with pituitary diabetes insipidusJ P Radó, J Marosi
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 1, 1975
Prolongation of duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) by ineffective doses of clofibrate in diabetes insipidusJ P Radó, J Marosi
Orvosi Hetilap|March 23, 1976
[Letter: Is Halidor a hallucinogen?]L Szende, J Marosi, J Radó
Metabolism: Clinical and Experimental|November 1, 1974
Influence of glyburide on the antidiuretic response induced by 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with pituitary diabetes insipidusJ R Radó, L Szende, J Marosi
Endokrinologie|January 1, 1970
Concentrating power of the kidney after five years of pitressin-tannate therapy in a patient with diabetes insipidus untreated for 13 years. (Investigations during intravenous administration of hypertonic sodium chloride, lysine-vasopressin, clopamide and furosemide)J P Radó, J Marosi, J Takó
Pharmacology|January 1, 1977
Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidusJ P Radó, J Marosi, J Fischer
Journal of Clinical Pharmacology|October 1, 1976
Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugsJ P Radó, J Marosi, J Fischer
Endokrinologie|January 1, 1970
High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronismJ P Radó, J Marosi, J Takó
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 1, 1976
Individual differences in the antidiuretic response induced by DDAVP in diabetes insipidusJ P Radó, J Marosi, L Borbély, et al.
Endokrinologie|December 1, 1973
Clinical value of the combinations of carbamazepine (tegretol), chlorpropamide (diabinese) and vasopressin in the treatment of pituitary diabetes insipidusJ P Radó, J Marosi, L Szende, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Endokrinologie|June 1, 1976
Lengthening of the duration of action of DDAVP by "ineffective" doses of clofibrate in patients with pituitary diabetes insipidusJ P Radó, J Marosi
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 1, 1975
Prolongation of duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) by ineffective doses of clofibrate in diabetes insipidusJ P Radó, J Marosi
Orvosi Hetilap|March 23, 1976
[Letter: Is Halidor a hallucinogen?]L Szende, J Marosi, J Radó
Metabolism: Clinical and Experimental|November 1, 1974
Influence of glyburide on the antidiuretic response induced by 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with pituitary diabetes insipidusJ R Radó, L Szende, J Marosi
Endokrinologie|January 1, 1970
Concentrating power of the kidney after five years of pitressin-tannate therapy in a patient with diabetes insipidus untreated for 13 years. (Investigations during intravenous administration of hypertonic sodium chloride, lysine-vasopressin, clopamide and furosemide)J P Radó, J Marosi, J Takó
Pharmacology|January 1, 1977
Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidusJ P Radó, J Marosi, J Fischer
Journal of Clinical Pharmacology|October 1, 1976
Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugsJ P Radó, J Marosi, J Fischer
Endokrinologie|January 1, 1970
High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronismJ P Radó, J Marosi, J Takó
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 1, 1976
Individual differences in the antidiuretic response induced by DDAVP in diabetes insipidusJ P Radó, J Marosi, L Borbély, et al.
Endokrinologie|December 1, 1973
Clinical value of the combinations of carbamazepine (tegretol), chlorpropamide (diabinese) and vasopressin in the treatment of pituitary diabetes insipidusJ P Radó, J Marosi, L Szende, et al.
Pageof 3